Acorda Therapeutics

Acorda Therapeutics announces $31.5 million financing

Published in Health Business Week, November 3rd, 2006

Acorda Therapeutics, Inc., (ACOR) announced that it has entered into a definitive purchase agreement with certain investors to raise approximately $31.5 million in gross proceeds through a private placement of newly issued shares of common stock, at a price of $9.75 per share.

The company intends to use the net proceeds from the financing to support its sales and marketing activities, advance its clinical and preclinical programs and for other working capital and general corporate purposes.

The securities to be sold in this private placement will not be registered under the Securities Act of 1933, as amended, or state securities laws and may not be...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Health Business Week

Source: Health Business Week (2006-11-03)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry

Search our medical news database